UBS AM’s iShares US Pharmaceuticals ETF IHE Stock Holding History

UBS AM’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Sell	288 -63	-18%	-$5.68K	﹤0.01%	3056
2026 Q1	$30.4K	Buy	351 +63	+22%	+$5.51K	﹤0.01%	3056
2025 Q4	$24.4K	Buy	+288	New	+$23K	﹤0.01%	2710
2017 Q1	–	Sell	-195	Closed	-$9K	–	2475
2016 Q4	$9K	Buy	+195	New	+$9.25K	﹤0.01%	2393

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

UBS AM's IHE Position: Q2 2026 in Review

UBS AM reduced its iShares US Pharmaceuticals ETF (IHE) stake by 18% in Q2 2026, selling an estimated $5.68K and leaving 288 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

UBS AM first reported a position in IHE in Q4 2016 and has held it in 4 quarters since. The position peaked at $30.4K in Q1 2026. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

UBS AM held 288 shares of iShares US Pharmaceuticals ETF worth $28.5K as of Q2 2026.
UBS AM sold 63 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $5.68K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3056 holding.
UBS AM first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and has held it in 4 quarters since.
UBS AM's iShares US Pharmaceuticals ETF position peaked at $30.4K in Q1 2026.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.